Arrowhead Research reported $0 in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0M 0.17M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Anika Therapeutics ANIK:US $ 0M 0M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Arrowhead Research ARWR:US $ 0 0
Bluebird Bio BLUE:US $ 0M 0M
Cerulean Pharma CERU:US $ 0 0
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1303M 62.3M
Ligand Pharmaceuticals LGND:US $ 316.89M 1.57M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 238M 90M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 24715M 1776M
Opko Health OPK:US $ 189.52M 0.21M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.38M 0.46M